Bruselix Tablets

Manufacturer
Puretek Corporation
Effective date
2024-10-11
Label type
HUMAN PRESCRIPTION DRUG LABEL
Version
1
Source
full-release
Hydrated at
2026-05-31 21:14:21

Label at a glance#

ProductBruselix Bruising
Active ingredientARNICA MONTANA FLOWER, STEM BROMELAIN, SODIUM ASCORBATE, HESPERIDIN METHYLCHALCONE, RUTIN, DIOSMIN, HESPERIDIN, ZINC PICOLINATE
Label structure10 sections

Indications and uses

Bruselix™ Bruising Tablets are formulated to provide nutritional support during the body’s natural recovery process. They may be helpful for individuals experiencing bruising due to minor injuries, surgical procedures, or sensitive skin. The formula contains antioxidants, enzymes, and natural extracts that are traditionally used to support overall skin health and recovery.

Dosage and administration

Take one (1) Bruselix™ Bruising Tablets daily, or as directed by a licensed healthcare practitioner. Do not exceed recommended dose.

Label contents#

Full prescribing information#

DESCRIPTION:

DESCRIPTION SECTION

Active Ingredients
Each tablet contains:

Vitamin C (as Sodium Ascorbate) ...............................................................120 mg
Zinc (as Zinc Picolinate) ...............................................................................10 mg
Arnica Montana Extract 10:1 (equivalent to 500 mg Arnica Montana Powder) ...50 mg
Bromelain 2400 GDU/g (from Pineapple) ...................................................400 mg
Diosmin (Citrus Aurantium) Fruit Extract.....................................................200 mg
Rutin (Sophora Japonica) Flower Extract......................................................50 mg
Citrus Bioflavonoids (from pulp and peel of lemon, orange, quince) ............25 mg
Hesperidin Methyl Chalcone..........................................................................25 mg

Other Ingredients: Croscarmellose Sodium, Dicalcium Phosphate, Magnesium Stearate, Microcrystalline Cellulose, Silicon Dioxide, Stearic Acid (Vegetable Source), Coating (Hydroxypropyl Methylcellulose, PEG-8).

INDICATIONS AND USAGE:

INDICATIONS & USAGE SECTION

Bruselix™ Bruising Tablets are formulated to provide nutritional support during the body’s natural recovery process. They may be helpful for individuals experiencing bruising due to minor injuries, surgical procedures, or sensitive skin. The formula contains antioxidants, enzymes, and natural extracts that are traditionally used to support overall skin health and recovery.

CONTRAINDICATIONS:

CONTRAINDICATIONS SECTION

Do not use if you have a known allergy to any of the ingredients in Bruselix™ Bruising Tablets, including Arnica Montana or pineapple (Bromelain). Avoid use if you have an allergy to citrus or bioflavonoid components.

WARNINGS AND PRECAUTIONS

WARNINGS AND PRECAUTIONS SECTION

Arnica: May cause allergic reactions in sensitive individuals, especially if there is a history of ragweed allergies.

Bromelain: May increase the risk of bleeding in individuals taking anticoagulants or antiplatelet medications. Discontinue use two weeks before surgery.

Zinc and Vitamin C: Use cautiously in individuals with kidney disease or those prone to kidney stones. If you experience an allergic reaction or prolonged bleeding, discontinue use and seek medical attention immediately.

For use on the order of a licensed healthcare practitioner.

Call your doctor about side effects. To report side effects, call PureTek Corporation at 1-877-921-7873.

Drug Interactions:

DRUG INTERACTIONS SECTION

The use of anticoagulants, such as warfarin or aspirin, may increase the risk of bleeding when combined with Bromelain. High doses of zinc can interfere with the absorption of iron when taken alongside iron supplements. Additionally, citrus bioflavonoids have the potential to enhance the effects of blood pressure-lowering medications.

Adverse Reactions:

ADVERSE REACTIONS SECTION

Adverse reactions associated with the use of Bruising Tablets may include mild gastrointestinal discomfort, nausea, or allergic reactions such as skin rash. In rare cases, more serious reactions, such as prolonged bleeding or hypersensitivity reactions (e.g., difficulty breathing, swelling), may occur. If you experience any serious adverse effects, discontinue use and seek medical attention immediately.

OVERDOSE:

OVERDOSAGE SECTION

In the event of overdose, seek medical attention immediately. Symptoms of overdose may include gastrointestinal upset, nausea, or an increased risk of bleeding due to excess Bromelain.

DOSAGE AND ADMINISTRATION:

DOSAGE & ADMINISTRATION SECTION

Take one (1) Bruselix™ Bruising Tablets daily, or as directed by a licensed healthcare practitioner. Do not exceed recommended dose.

HOW SUPPLIED:

HOW SUPPLIED SECTION

Bruselix™ Bruising Tablets are yellow to brown speckled, clear-coated tablets, packaged in a bottle containing 14 tablets – NDC 59088-003-81.

KEEP THIS AND ALL MEDICATIONS OUT OF THE REACH OF CHILDREN. Store at 20°-25°C (68°-77°F) [see USP Controlled Room Temperature]

LABEL

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Manufactured by:
PureTek Corporation

Panorama City, CA 91402
For questions or information
call toll-free: 877-921-7873

LabelLabel

DailyMed Pharmacologic Classes#

Class, Version, Type table
ClassVersionTypeEffective
ASCORBIC ACID Pharmacologic Class Indexing2Indexing - Pharmacologic Class20180813
ZINC CATION Pharmacologic Class Indexing2Indexing - Pharmacologic Class20180813

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
f47a510b-6679-4664-b2d6-47b5c4afe7ccProduct name420260217
030ce964-9b2d-45aa-b5d3-f78ce03ef61cProduct name220250515
0306390c-dd77-4363-afe0-63c58088b2a1Product name120220120
503ea967-4b9c-48cf-9e87-c7975295849dProduct name220220120
c5cd4727-ac49-4409-82b1-5bd8006c3ec7Product name120171122
190f2a5b-bbc8-65c7-fcb0-97891307b917Product name120140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
59088-003-81Bruselix Bruising14 in 1 BOTTLE, PLASTICTABLET141

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
59088-003BRUSELIX BRUISING (VITAMIN C, ZINC, ARNICA MONTANA EXTRACT, BROMELAIN, DIOSMIN, RUTIN, CITRUS BIOFLAVONOIDS, HESPERIDIN METHYL CHALCONE) TABLET [PURETEK CORPORATION]1Current NDC, 1 package rows20241013_24245e80-529f-0542-e063-6394a90a1fb4.zip

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
59088-003-81EA - Each59088-0034faec017-db57-4ad0-a3e0-e46f09f9812012024-11-05

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 20 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
59088-00359088-003-81

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 16 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Bruselix BruisingVITAMIN C, ZINC, ARNICA MONTANA EXTRACT, BROMELAIN, DIOSMIN, RUTIN, CITRUS BIOFLAVONOIDS, HESPERIDIN METHYL CHALCONEPuretek Corporation24245e80-529f-0542-e063-6394a90a1fb42024-10-11Warnings, Adverse reactionsExact identifier
ndc (package): 59088-003-81
ndc (product): 59088-003
ndc11 (package): 59088000381
spl id: 24245e80-529f-0542-e063-6394a90a1fb4
spl set id: 24245e80-529f-0542-e063-6394a90a1fb4

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.